BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38057852)

  • 1. Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway.
    Li M; Bai G; Cen Y; Xie Q; Chen J; Chen J; Chen Q; Zhong W; Zhou X
    J Transl Med; 2023 Dec; 21(1):884. PubMed ID: 38057852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.
    Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikström P
    Eur Urol; 2017 May; 71(5):776-787. PubMed ID: 27497761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine starvation elicits chromatin leakage and cGAS-STING activation via epigenetic silencing of metabolic and DNA-repair genes.
    Hsu SC; Chen CL; Cheng ML; Chu CY; Changou CA; Yu YL; Yeh SD; Kuo TC; Kuo CC; Chuu CP; Li CF; Wang LH; Chen HW; Yen Y; Ann DK; Wang HJ; Kung HJ
    Theranostics; 2021; 11(15):7527-7545. PubMed ID: 34158865
    [No Abstract]   [Full Text] [Related]  

  • 5. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
    Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
    Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA damage-triggered activation of cGAS-STING pathway induces apoptosis in human keratinocyte HaCaT cells.
    Li C; Liu W; Wang F; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Mol Immunol; 2021 Mar; 131():180-190. PubMed ID: 33423764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway.
    García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
    Zhuo X; Dai H; Yu S
    Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Chen X; Ma J; Wang X; Zi T; Qian D; Li C; Xu C
    Front Endocrinol (Lausanne); 2022; 13():1106175. PubMed ID: 36601001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development.
    He H; Hao J; Dong X; Wang Y; Xue H; Qu S; Choi SYC; Ci X; Wang Y; Wu R; Shi M; Zhao X; Collins C; Lin D; Wang Y
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):775-785. PubMed ID: 33568749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels.
    Basit A; Cho MG; Kim EY; Kwon D; Kang SJ; Lee JH
    Exp Mol Med; 2020 Apr; 52(4):643-657. PubMed ID: 32284536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontypeable Haemophilus influenzae DNA stimulates type I interferon expression via STING signaling pathway.
    Lu C; Zhang X; Ma C; Xu W; Gan L; Cui J; Yin Y; Wang H
    Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):665-673. PubMed ID: 29421524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
    Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
    Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer.
    Gu P; Chen X; Xie R; Xie W; Huang L; Dong W; Han J; Liu X; Shen J; Huang J; Lin T
    Mol Cancer; 2019 Jun; 18(1):109. PubMed ID: 31221168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells.
    Morimoto D; Matsumura S; Bustos-Villalobos I; Sibal PA; Ichinose T; Naoe Y; Eissa IR; Abdelmoneim M; Mukoyama N; Miyajima N; Tanaka M; Kodera Y; Kasuya H
    Cells; 2021 Jun; 10(6):. PubMed ID: 34203706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Porcine Cyclic GMP-AMP Synthase-STING Pathway Exerts an Unusual Antiviral Function Independent of Interferon and Autophagy.
    Jiang S; Xia N; Luo J; Zhang Y; Cao Q; Zhang J; Wang Y; Zhao Y; Zheng W; Chen N; Meurens F; Li X; Zhu J
    J Virol; 2022 Dec; 96(23):e0147622. PubMed ID: 36377876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma.
    Jiang X; Li Y; Zhang N; Gao Y; Han L; Li S; Li J; Liu X; Gong Y; Xie C
    Cell Biosci; 2021 Apr; 11(1):74. PubMed ID: 33858512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
    Roudier MP; Winters BR; Coleman I; Lam HM; Zhang X; Coleman R; Chéry L; True LD; Higano CS; Montgomery B; Lange PH; Snyder LA; Srivastava S; Corey E; Vessella RL; Nelson PS; Üren A; Morrissey C
    Prostate; 2016 Jun; 76(9):810-22. PubMed ID: 26990456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.